Skip to main content

Table 3 Cardiac function data comparison in control group with different suppression time

From: Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma

 

Group D: within half a year (17 patients)

Group E: between half a year and a year (8 patients)

Group F: more than a year (16 patients)

PDE

PDF

PEF

EF (%)

75.05 ± 9.60

72.50 ± 5.63

57.61 ± 7.75

0.798

0.030

0.037

PER (EDV/s)

4.01 ± 0.86

3.81 ± 0.36

2.66 ± 0.82

0.857

0.401

0.035

PFR (EDV/s)

3.71 ± 0.90

3.22 ± 0.52

2.00 ± 0.73

0.395

0.028

0.004

MFR/3 (EDV/s)

1.36 ± 0.41

1.68 ± 0.20

0.55 ± 0.31

0.138

0.246

0.006

TTPF (ms)

156.94 ± 28.01

153.33 ± 33.59

117.77 ± 13.30

0.945

0.994

0.016

BMP

88.17 ± 7.98

77.15 ± 7.23

52.97 ± 13.80

0.098

0.001

0.010

Bandwidth

22.82 ± 17.29

39.94 ± 29.22

22.89 ± 8.80

0.087

0.423

0.019

Mean angle (°)

156.06 ± 14.21

142.33 ± 14.27

101.15 ± 18.30

0.187

0.060

0.004

Angle STD (°)

5.40 ± 6.32

10.63 ± 10.61

7.02 ± 6.77

0.291

0.786

0.544

Entropy (%)

22.88 ± 10.51

33.33 ± 14.79

21.94 ± 12.95

0.185

0.448

0.013

SRS

0.82 ± 0.48

0.67 ± 1.63

1.67 ± 1.88

0.973

0.195

0.307

Reduced perfusion ratio (%)

11.76

16.67

61.11

  1. EF ejection fraction, PER peak ejection rate, EDV end-diastolic volume, PFR peak filling rate, MFR/3 mean filling rate over the first third of the end-systolic to end diastolic phase, TTPF time to peak filling from end-systole, BMP beats per minute, STD standard deviation, SRS summed rest score